Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.24 | 0.28% | 86.34 | 86.71 | 86.02 | 86.44 | 86.10 | 10:46:16 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12,761 | 2,506,107 | $ 86.44 | $ 216,640,369 | 8,517,924 | 72.05 - 92.64 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:46:16 | 52 | $ 86.3312 | USD |
Merck Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 220.16B | 2.55B | $ 6.22B | 2.32 | 24.20 | 2.54B |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 25.15M | $ 1.99 | 2.30% | 12/13/19 | - | - |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 90.72 | 91.01 | 84.71 | 87.78 | 10,838,824 | -4.38 | -4.83% |
| 1 Month | 90.97 | 92.44 | 84.71 | 89.40 | 9,046,651 | -4.63 | -5.09% |
| 3 Months | 83.67 | 92.64 | 82.50 | 88.02 | 8,127,828 | 2.67 | 3.19% |
| 6 Months | 82.12 | 92.64 | 78.85 | 85.80 | 8,335,913 | 4.22 | 5.14% |
| 1 Year | 72.38 | 92.64 | 72.05 | 82.73 | 9,337,012 | 13.96 | 19.29% |
| 3 Years | 61.52 | 92.64 | 52.83 | 69.86 | 9,580,635 | 24.82 | 40.34% |
| 5 Years | 62.82 | 92.64 | 45.69 | 64.68 | 9,527,601 | 23.52 | 37.44% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States. |
